Abstract
Idiopathic intracranial hypertension (IIH) primarily affects young obese females, and potentially causes visual loss and severe headache. The aim of this experiment is to examine relapse rate and long-term outcome in IIH patients. The methods involved in this experiment include a prospective controlled study of 18 newly diagnosed IIH patients followed for a mean observation period of 21.1 (±8.0) months. Treatment regime included diuretics, dietary recommendations and check-up visits at a dietician. Baseline and follow-up included neurological examination, detailed headache history and comprehensive neuro-ophthalmological examination, including fundus photography, Humphrey visual fields, and measurement of the retinal thickness (RT) and retinal nerve fiber layers (RNFL) by optical coherence tomography (OCT). Relapse was defined as recurrence of either: (1) papilledema or (2) symptoms and demonstrated raised ICP. The result of this experiment is that relapse was found in 28%. Visual function improved from baseline to follow-up and was generally favorable. In patients without relapse of papilledema RT and RNFL were significantly thinner than in healthy controls (p = 0.003 and 0.02), although atrophy was clinically detectable in only one patient. Headache was still present in 67% of the patients at follow-up. Headache was heterogenic and unrelated to relapse. After an initial reduction, weight increased again in the relapse group compared to reduced weight in the non-relapse group (p = 0.013). Thus, the conclusions drawn are that headache was persistent, difficult to classify, and equally represented in relapse and non-relapse patients. Headache was thus a poor marker of active disease. Relapse rate was high and clinically undetectable optic disc atrophy was discovered in apparently well treated IIH patients.
References
(2004) The International Classification of Headache Disorders: 2nd edn Cephalalgia 24 (Suppl 1):9–160
Arienta C, Caroli M, Balbi S, Parma A, Calappi E, Massei R (1990) Clinical evaluation and long-term follow-up in 16 patients with pseudo tumour cerebri. Acta Neurochir Suppl (Wien) 51:369–371
Arseni C, Simoca I, Jipescu I, Leventi E, Grecu P, Sima A (1992) Pseudotumor cerebri: risk factors, clinical course, prognostic criteria. Rom J Neurol Psychiatry 30:115–132
Banta JT, Farris BK (2000) Pseudotumor cerebri and optic nerve sheath decompression. Ophthalmology 107:1907–1912
Binder DK, Horton JC, Lawton MT, McDermott MW (2004) Idiopathic intracranial hypertension. Neurosurgery 54:538–551
Borgbjerg BM, Gjerris F, Albeck MJ, Borgesen SE (1995) Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts. Acta Neurochir (Wien) 136:1–7
Borgbjerg BM, Gjerris F, Albeck MJ, Hauerberg J, Borgesen SE (1995) Frequency and causes of shunt revisions in different cerebrospinal fluid shunt types. Acta Neurochir (Wien) 136:189–194
Brazis PW (2009) Surgery for idiopathic intracranial hypertension. J Neuroophthalmol 29:271–274
Corbett JJ, Savino PJ, Thompson HS, Kansu T, Schatz NJ, Orr LS, Hopson D (1982) Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol 39:461–474
Digre KB, Nakamoto BK, Warner JE, Langeberg WJ, Baggaley SK, Katz BJ (2009) A comparison of idiopathic intracranial hypertension with and without papilledema. Headache 49:185–193
Durcan FJ, Corbett JJ, Wall M (1988) The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol 45:875–877
Friedman DI (2008) Pseudotumor cerebri presenting as headache. Expert Rev Neurother 8:397–407
Friesner D, Rosenman R, Lobb BM, Tanne E (2011) Idiopathic intracranial hypertension in the USA: the role of obesity in establishing prevalence and healthcare costs. Obes Rev 12:e372–e380
Frisen L (1982) Swelling of the optic nerve head: a staging scheme. J Neurol Neurosurg Psychiatry 45:13–18
Giuseffi V, Wall M, Siegel PZ, Rojas PB (1991) Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study. Neurology 41:239–244
Goh KY, Schatz NJ, Glaser JS (1997) Optic nerve sheath fenestration for pseudotumor cerebri. J Neuroophthalmol 17:86–91
Kesler A, Hadayer A, Goldhammer Y, Almog Y, Korczyn AD (2004) Idiopathic intracranial hypertension: risk of recurrences. Neurology 63:1737–1739
Kupersmith MJ, Gamell L, Turbin R, Peck V, Spiegel P, Wall M (1998) Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology 50:1094–1098
Laemmer R, Heckmann JG, Mardin CY, Schwab S, Laemmer AB (2010) Detection of nerve fiber atrophy in apparently effectively treated papilledema in idiopathic intracranial hypertension. Graefes Arch Clin Exp Ophthalmol 248:1787–1793
Lepore FE (1992) Unilateral and highly asymmetric papilledema in pseudotumor cerebri. Neurology 42:676–678
Lipton HL, Michelson PE (1972) Pseudotumor cerebri syndrome without papilledema. JAMA 220:1591–1592
Lysak WR, Svien HJ (1966) Long-term follow-up on patients with diagnosis of pseudotumor cerebri. J Neurosurg 25:284–287
Marcelis J, Silberstein SD (1991) Idiopathic intracranial hypertension without papilledema. Arch Neurol 48:392–399
Mathew NT, Ravishankar K, Sanin LC (1996) Coexistence of migraine and idiopathic intracranial hypertension without papilledema. Neurology 46:1226–1230
Murphy TP (1991) Otologic manifestations of pseudotumor cerebri. J Otolaryngol 20:258–261
Newborg B (1974) Pseudotumor cerebri treated by rice reduction diet. Arch Intern Med 133:802–807
Plotnik JL, Kosmorsky GS (1993) Operative complications of optic nerve sheath decompression. Ophthalmology 100:683–690
Radhakrishnan K, Ahlskog JE, Cross SA, Kurland LT, O’Fallon WM (1993) Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976–1990. Arch Neurol 50:78–80
Radhakrishnan K, Thacker AK, Bohlaga NH, Maloo JC, Gerryo SE (1993) Epidemiology of idiopathic intracranial hypertension: a prospective and case-control study. J Neurol Sci 116:18–28
Reddy GK, Bollam P, Shi R, Guthikonda B, Nanda A (2011) Management of adult hydrocephalus with ventriculoperitoneal shunts: long-term single-institution experience. Neurosurgery 69:774–781
Round R, Keane JR (1988) The minor symptoms of increased intracranial pressure: 101 patients with benign intracranial hypertension. Neurology 38:1461–1464
Rowe FJ (2011) Assessment of visual function in idiopathic intracranial hypertension. Br J Neurosurg 25:45–54
Rowe FJ, Sarkies NJ (1998) Assessment of visual function in idiopathic intracranial hypertension: a prospective study. Eye (Lond) 12(Pt 1):111–118
Shah VA, Kardon RH, Lee AG, Corbett JJ, Wall M (2008) Long-term follow-up of idiopathic intracranial hypertension: the Iowa experience. Neurology 70:634–640
Sinclair AJ, Burdon MA, Nightingale PG, Ball AK, Good P, Matthews TD, Jacks A, Lawden M, Clarke CE, Stewart PM, Walker EA, Tomlinson JW, Rauz S (2010) Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ 341:c2701
Skau M, Milea D, Sander B, Wegener M, Jensen R (2011) OCT for optic disc evaluation in idiopathic intracranial hypertension. Graefes Arch Clin Exp Ophthalmol 249:723–730
Skau M, Sander B, Milea D, Jensen R (2011) Disease activity in idiopathic intracranial hypertension: a 3-month follow-up study. J Neurol 258:277–283
Sorensen PS, Thomsen AM, Gjerris F (1986) Persistent disturbances of cognitive functions in patients with pseudotumor cerebri. Acta Neurol Scand 73:264–268
Thambisetty M, Lavin PJ, Newman NJ, Biousse V (2007) Fulminant idiopathic intracranial hypertension. Neurology 68:229–232
Wall M (1990) The headache profile of idiopathic intracranial hypertension. Cephalalgia 10:331–335
Wall M, George D (1991) Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 114:155–180
Wang SJ, Silberstein SD, Patterson S, Young WB (1998) Idiopathic intracranial hypertension without papilledema: a case-control study in a headache center. Neurology 51:245–249
Weisberg LA (1975) Benign intracranial hypertension. Medicine (Baltimore) 54:197–207
Wong R, Madill SA, Pandey P, Riordan-Eva P (2007) Idiopathic intracranial hypertension: the association between weight loss and the requirement for systemic treatment. BMC Ophthalmol 7:15
Acknowledgments
The studies have been approved by the appropriate ethics committee and have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yri, H.M., Wegener, M., Sander, B. et al. Idiopathic intracranial hypertension is not benign: a long-term outcome study. J Neurol 259, 886–894 (2012). https://doi.org/10.1007/s00415-011-6273-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-011-6273-9